Story thread · 2 reports / 2 sources
Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care
thestar.com · 3h · first report
Long-acting injectables (LAIs) offer an opportunity to improve adherence and potential outcomes for patients with schizophreniaLongActingImpact.com is a new resource center designed to support clinicians in having informed treatment conversations with those living with schizophreniaAs a leader in neuroscience, Teva…
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.